$BDSI Company News Microsoft, Starbucks shares rise

New Post Public Reply Private Reply Replies (0) Message Board

Jun 9, 2014 at 10:26 AM

$BDSI Company News

Microsoft, Starbucks shares rise after earnings reports 7:30 p.m. Jan. 23, 2014 - Wallace Witkowski
Top 10 U.S. cities for growing businesses 8:48 p.m. April 15, 2013 - Russ Britt
What 2012’s winners and losers say about 2013 7:00 a.m. Dec. 14, 2012 - Howard Gold
BioDelivery to get milestone payment; shares leap 12:54 p.m. Feb. 16, 2012 - MarketWatch.com
BioDelivery to get up to $180M in Endo Pharma pact 8:03 a.m. Jan. 6, 2012 - MarketWatch.com
Wednesday's biggest stock gainers and decliners 7:20 p.m. April 25, 2007 - MarketWatch
Updates, advisories and surprises 6:31 p.m. April 25, 2007 - MarketWatch
BioDelivery Sciences up 76% at $8.01 9:59 a.m. April 25, 2007 - Tomi Kilgore
BioDelivery Sciences Phase III trial shows positive results 6:39 a.m. April 25, 2007 - Simon Kennedy
BioDelivery Sciences says positive Phase III Fentanyl trial 6:12 a.m. April 25, 2007 - Steve Goldstein
Highlights of rising and falling U.S. stocks 6:15 p.m. March 2, 2006 - MarketWatch
BioDelivery Sciences off after nausea treatment setback 11:57 a.m. March 2, 2006 - Michael Baron
Highlights of rising and falling U.S. stocks 2:23 p.m. Sept. 30, 2005 - Michael Baron
BioDelivery prices 4.4 million shares at $2 each 8:21 a.m. Sept. 30, 2005 - Thomas Middleton
Biodelivery Sciences prices offer of 4.4M shares at $2 per 8:19 a.m. Sept. 30, 2005 - Michael Baron
BioDelivery prices 4.4M shares at $2 each 8:05 a.m. Sept. 30, 2005 - Thomas Middleton
BioDelivery Sciences:FDA to review nausea treatment app 10:49 a.m. July 20, 2005 - Carla Mozee
BioDelivery Sciences:FDA to review nausea treatment app 10:39 a.m. July 20, 2005 - Carla Mozee
BioDelivery Sciences: FDA accepts Emezine for review 10:38 a.m. July 20, 2005 - Carla Mozee
BioDelivery to get $7M for Phase III cancer-pain study 11:39 a.m. July 18, 2005 - Carla Mozee

BioDelivery Sciences International (BDSI): Heavy Pre-Market Activity 8:41 a.m. Today - TheStreet.com
The IBB Likely To Move Higher Along With These Biotechs With Catalysts Upcoming 8:30 a.m. June 2, 2014 - Seeking Alpha
BioDelivery Sciences International Inc Stock Downgraded (BDSI) 11:11 a.m. May 30, 2014 - TheStreet.com
Orexigen Will Run: Here's Why 3:47 p.m. May 27, 2014 - Seeking Alpha
2nd Half Of 2014 Biotechnology Catalysts: Part 1 9:34 a.m. May 27, 2014 - Seeking Alpha
Pipeline Update from BioDelivery Sciences - Analyst Blog 5:50 p.m. May 14, 2014 - Zacks.com
BioDelivery Sciences International's CEO Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript) 6:35 a.m. May 14, 2014 - Seeking Alpha
BioDelivery Sciences International Inc Stock Upgraded (BDSI) 11:11 a.m. May 13, 2014 - TheStreet.com
2014 FDA Drug Approval Calendar 9:22 a.m. May 12, 2014 - TheStreet.com
Oversold Conditions For BioDelivery Sciences International (BDSI) 12:08 p.m. April 14, 2014 - TheStreet.com
BioDelivery Sciences' Clonidine in Phase III Study - Analyst Blog 6:25 p.m. April 4, 2014 - Zacks.com
BioDelivery Sciences: 4 Different Insiders Have Sold Shares This Month 3:45 a.m. March 31, 2014 - Seeking Alpha
BioDelivery Sciences and Quintiles Sign Deal for Bunavail - Analyst Blog 11:30 a.m. March 28, 2014 - Zacks.com
Pipeline Update from BioDelivery Sciences - Analyst Blog 5:00 p.m. March 18, 2014 - Zacks.com
BioDelivery Sciences reviews its business and updates milestones for 2014 9:01 a.m. March 14, 2014 - Seeking Alpha
10-K: BIODELIVERY SCIENCES INTERNATIONAL INC 6:14 a.m. March 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
BioDelivery Sciences International (BDSI) Jumps: Stock Up 8.5% - Tale of the Tape 10:39 a.m. Feb. 11, 2014 - Zacks.com
3 Pharmaceutical Stocks to Buy Now 8:15 a.m. Jan. 31, 2014 - InvestorPlace.com
BioDelivery Sciences International (BDSI) Soars: Stock Up 50.6% - Tale of the Tape 9:51 a.m. Jan. 27, 2014 - Zacks.com
Can The Uptrend Continue for BioDelivery Sciences (BDSI)? - Tale of the Tape 8:01 a.m. Jan. 27, 2014 - Zacks.com

BioDelivery Sciences Receives FDA Approval for BUNAVAIL™ (buprenorphine and naloxone) Buccal Film for the Maintenance Treatment of Opioid Dependence 7:00 a.m. Today - PR Newswire - PRF
BioDelivery Sciences Receives FDA Approval for BUNAVAIL™ (buprenorphine and naloxone) Buccal Film for the Maintenance Treatment of Opioid Dependence 5:19 p.m. June 6, 2014 - PR Newswire - PRF
Technical Coverage on Top Gainers -- Research on Noranda Aluminum Holding, Teekay Tankers, BioDelivery Sciences Intl. and Quality Systems 6:00 a.m. May 27, 2014 - PR Newswire - PRF
BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2014 Financials 6:00 p.m. May 8, 2014 - PR Newswire - PRF
BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2014 Health Care Conference 7:00 a.m. May 8, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Randomization of Over 50% of Subjects in its Initial Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy 7:00 a.m. May 6, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Four BUNAVAIL Abstracts to be Presented at the 2014 American Society of Addiction Medicine Annual Conference 9:40 a.m. April 7, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Enrollment of the First Patient in a Phase 3 Clinical Study of Clonidine Topical Gel for Painful Diabetic Neuropathy 7:00 a.m. April 3, 2014 - PR Newswire - PRF
Foresite Capital Closes $300 Million Fund II to Finance Late-Stage Healthcare Companies 8:03 a.m. April 1, 2014 - BusinessWire - BZX
BioDelivery Sciences Announces Commercialization Agreement with Quintiles to Support the Launch of BUNAVAIL in the U.S. 7:00 a.m. March 27, 2014 - PR Newswire - PRF
BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its 2013 Annual Report 6:30 a.m. March 14, 2014 - PR Newswire - PRF
Equities Hitting New High: Allergan, Aetna, Ecolab, and BioDelivery Sciences Intl. 12:17 p.m. March 12, 2014 - PR Newswire - PRF
BioDelivery Sciences to Present at the 26th Annual ROTH Conference 8:00 a.m. March 5, 2014 - PR Newswire - PRF
BioDelivery Sciences to Present at the Cowen and Company 34th Annual Health Care Conference 8:00 a.m. Feb. 28, 2014 - PR Newswire - PRF
BioDelivery Sciences Closes $60 Million Registered Direct Offering 8:00 a.m. Feb. 13, 2014 - PR Newswire - PRF
BioDelivery Sciences to Raise $60 Million in Registered Direct Offering From Institutional Investors 8:00 a.m. Feb. 10, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Four BUNAVAIL Abstracts to be Presented at the 2014 American Society of Addiction Medicine Annual Conference 8:00 a.m. Jan. 30, 2014 - PR Newswire - PRF
Endo and BioDelivery Sciences Announce Positive Top-Line Results from the Phase III Clinical Trial of BEMA Buprenorphine in Opioid Naive Patients with Chronic Pain 5:30 p.m. Jan. 23, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Hiring of David Acheson as Vice President of Sales and Managed Markets 9:30 a.m. Dec. 3, 2013 - PR Newswire
Positive FDA Meeting Confirms BDSI Phase 3 Program for Clonidine Topical Gel for Treatment of Painful Diabetic Neuropathy 8:00 a.m. Dec. 2, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Metriport Eyes Major Step in Health Data Integration

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Airswift's Strategic Acquisition Boosts U.S. Energy Presence

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Chad Tucker's Sequel Explores Deep Spiritual Themes

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

WareSpace Expands Reach With $36.5M Acquisitions

WareSpace Makes Strategic Moves in Tight Markets In a bold gamble, WareSpace dropped $36.5 million to snag fresh industrial real estate in Miami Gardens, Florida, and South San Francisco, California. These aren't random picks, mind you. They're strategic grabs in markets where finding space ain't easier than winning the lottery. With more than 210 flexible units for small...

AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Trust vs. AI: Shapira's Fight in Modern Speechcraft

Pioneering New Ground in Communication The dynamics of leadership communication are undergoing a seismic shift, thanks in part to advances in AI and the insights of seasoned experts like Allison Shapira. Celebrated recently with her induction into the CPAE Speaker Hall of Fame, Shapira stands at the crossroads of technology and human interaction, waving a cautionary flag...

Bud Ecosystem Debuts AIOS, Aims to Slash Costs

AI Fragmentation Tax: Cut It Out! Look, if you think AI is all about fancy algorithms and self-learning voodoo, you're missing the plot. It's the nuts and bolts—the infrastructure—that's been bleeding enterprises dry. That's where Bud Ecosystem comes thrashing in with its Novaria AIOS. They're not just promising a tiny tune-up; they're talking slashing AI costs by a...

Donatos Targets Texas: Pushing Franchise Growth Limits

Donatos Pizza: Ambitious Expansion in the Lone Star State When you think about pizza chains expanding, Donatos Pizza might not be the first name to come to mind, but they're cooking up something big in Texas. Folks in Dallas and Houston better be ready because Donatos is rolling out the red carpet for its edge-to-edge, topping-loaded pies all over Texas. Strategic Growth:...

Guaranteed Roof Expands with EM Exteriors through LB Capital

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

American Savings Bank Surges 6% on NYSE Debut

American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...